share_log

TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024

TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024

transmedics將於2024年10月28日發佈2024年第三季度財務業績。
PR Newswire ·  10/16 04:05

ANDOVER, Mass., Oct. 15, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2024 after market close on Monday, October 28, 2024. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

馬薩諸塞州安多弗,2024年10月15日新聞稿——transmedics集團公司("transmedics")(納斯達克股票代碼: TMDX),一家醫療科技公司,正在改變終末期肺部、心臟和肝臟衰竭患者的器官移植治療,今天宣佈將於2024年10月28日星期一市場收盤後發佈2024年第三季度財務業績。transmedics管理團隊將在東部時間下午4:30 / 太平洋時間下午1:30 開始舉行相應電話會議。

Investors interested in listening to the conference call may do so by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at .

有興趣收聽電話會議的投資者可以撥打(844)481-2832(美國國內)或(412)317-1852(國際),並要求加入transmedics的電話會議。該活動的現場直播和存檔網絡視頻將在transmedics網站的"投資者"頁面上提供。 .

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

關於transmedics group,inc。
transmedics是世界上便攜式體外溫熱灌注和評估供體器官移植的領先者。該公司總部位於美國馬薩諸塞州安多弗,旨在解決器官移植的需求問題,開發出了保存器官質量、評估器官移植前的可能性和潛在增加供體器官利用率的技術,用於治療終末心臟、肺和肝功能衰竭。

Investor Contact:
Brian Johnston
332-895-3222
[email protected]

投資者聯繫人:
Brian Johnston
332-895-3222
[email protected]

SOURCE TransMedics Group, Inc.

資料來源:transmedics group,inc。

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力
9k+
9k+

Digital Media
數字媒體

Outlets
賣場
270k+
270k+

Journalists
新聞記者

Opted In
已選擇加入
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論